Value-based healthcare is pushing radiologists to deliver the highest quality of care while optimizing time and processes.  At RSNA 2013, Nuance will showcase its latest version of PowerScribe 360 — a radiology reporting and communication platform. Powerscribe 360 version 2.0 offers new features like the 99 percent accurate Dragon Medical 12 speech recognition engine, as well as automation tools that increase data accuracy and the speed at which an actionable, structured report is completed. 

Parker Laboratories is introducing three, completely redesigned Thermasonic Gel Warmers at RSNA 2013. These include a single bottle gel warmer, a three-bottle gel warmer with preset temperature options and LED indicators, and a three-bottle gel warmer with LCD readout and temperature adjustment in one degree increments, in either Fahrenheit or Celsius.


 Limiting the amount of radiation absorbed in the hippocampal portion of the brain during whole-brain radiotherapy (WBRT) for brain metastases preserves memory function in patients for up to six months after treatment, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
FDA regulates apps, mobile devices

In an effort to guide regulation of mobile medical apps, the U.S. Food and Drug Administration (FDA) issued a final guidance document for developers of mobile medical apps. 
Choosing Wisely ASTRO 2013 Radiation Therapy

The American Society for Radiation Oncology (ASTRO) released its list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate as part of the national Choosing Wisely campaign, an initiative of the ABIM Foundation. The list identifies five targeted treatment options that ASTRO recommends for detailed patient-physician discussion before being prescribed.

The American Society for Radiation Oncology (ASTRO) highlighted the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, Sept. 22-25, 2013, in Atlanta.

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission tomography (PET) radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.


When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.

The ASRT Foundation and RAD-AID International have announced plans to offer a program for radiation therapists to teach in China.

At the 55th American Society for Radiation Oncology (ASTRO) annual meeting, September 22-25 in Atlanta, Royal Philips featured the latest innovations that address efficient and personalized radiation oncology care for patients and their clinicians.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now